Vaccine against nicotine may help users kick the habit

05/16/2005 | Los Angeles Times (tiered subscription model)

A vaccine against nicotine being tested in Switzerland helped nearly 60% of smokers who achieved a high level of antibodies stop smoking for at least six months, according to researchers at the University of Lausanne. Four companies reportedly are studying nicotine vaccines, including Cytos Biotechnology of Zurich, whose vaccine was tested, Xenova Group of Britain and U.S. firms Nabi Biopharmaceuticals and Prommune.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX